Navigation Links
QLT reports initial proof of concept data for punctal plug delivery technology
Date:5/12/2008

Small study supports the potential for QLT's drug elution technology to

reduce and sustain intraocular pressure

VANCOUVER, May 12 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced today results from a proof of concept trial conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc., of its punctal plug drug delivery technology. The results demonstrated that QLT's drug elution technology was effective in controlling intraocular pressure (IOP) and was well tolerated.

The proof of concept, open label study was initiated to determine if a sustained administration of latanoprost using the Company's punctal plug drug delivery technology could lead to a reduction in IOP over 90 days when administered using a conventional plug design. Five patients (10 eyes) with glaucoma or ocular hypertension were enrolled at a single center. The primary efficacy endpoint was measurement of IOP. At baseline, the mean IOP was 23mmHg for the 10 eyes treated. At 90 day follow-up, the mean IOP was reduced to 17mmHg for the six eyes that remained. Data from two patients were excluded due to loss of plugs. No significant adverse events were reported.

"We are very pleased to report positive results from this preliminary proof of concept trial", said Bob Butchofsky, President and Chief Executive Officer of QLT. "Although the number of patients is small, we are encouraged by the clinically meaningful reduction in IOP that was observed and sustained for approximately 90 days. We look forward to providing you with additional details from this study at our Annual General Meeting on Wednesday, May 14."

The objective of QLT's punctal plug program is to demonstrate that the Company's drug elution technology leads to a statistically significant reduction in IOP for 90 days and that its proprietary punctal plug design can be retained comfortably in a high percentage of patients during that time period. The results presented t
'/>"/>

SOURCE QLT Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Neurobiological Technologies Reports Third Quarter Financial Results
2. Bionovo Reports First Quarter 2008 Financial Results
3. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
4. Cardium Reports on First Quarter 2008 Highlights and Financial Results
5. Novavax Reports First Quarter 2008 Financial Results
6. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
7. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
8. Pharmos Corporation Reports 2008 First Quarter Results
9. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
10. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008
11. Favrille Reports First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...EN, Nov. 19 Danish Prince Joachim ... ethanol plant in Kalundborg, Denmark, on Wednesda... first and largest 2nd generation ethanol demonstr...s are used in the plant,s innovative process for c...anisco, was the first to market with commercial en...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha...he previously reported $6.3 million registered dir...870 shares of its common stock and warrants to pur...
(Date:11/19/2009)...VERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswire/... Resources find that the leading driver of antibio... broad-spectrum activity against gram-positive and...ganisms that can cause nosocomial pneumonia, surve...arily for agents that provide appropriate coverage...
(Date:11/19/2009)... Top LASIK surgeons and recognized refracti...LASIK Surgeons made brought their fellow surgeons ...rrection surgery, cataract surgery, and ophthalmol...Academy of Ophthalmology (AAO) annual meeting in S...r. Shachar Tauber, Dr. David Huang, MD, Dr. Randy ...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
...eb. 5 CryoLife, Inc. (NYSE: CRY ), a biomateria...announced today that 2008 fourth quarter and year ..., February 19, 2009. The Company will hold a tele...tern Time, February 19, 2009, to discuss the resul...ed by Steven G. Anderson, president and CEO of Cry...
...Md., Feb. 5 Micromet, Inc. (Nasdaq: MITI ), tod...tian Itin, will present at the BIO CEO and Investo...ty on Tuesday, February 10, 2009. A simultaneous w...e company,s website at www.micromet-inc.com . , ...: Tuesday, February 10, 2009, Time: 2:1...
... N.J., Feb. 5 Sopherion Therapeutics, LLC, a biop...nd commercialization of anti-cancer therapies, tod...I/II study of nonpegylated liposomal doxorubicin (...cer Research . The study was supported by a grant...t Cancer Cooperative Group (SOLTI). , , The study...
Other Biology Technology:CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 3Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 4Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 2Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 3Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 4
(Date:11/20/2009)...T researchers are at work on many scientific and t...ation has recently provided support that totals ne...ollowing investigators under the American Recovery...ers have been awarded grants for investigation of ...ofessor of physics, will enhance the capabilities ...
(Date:11/20/2009)...RBOR, Mich.---We,ve all read studies about the hea...ing is true at the molecular level, where amino ac... damage when single than when paired up with other... of Michigan, along with colleagues in Belgium, ha...ts single cysteines. The research appears in the N...
(Date:11/20/2009)...ade ago, a group of University of Oklahoma researc... part of the human genome project. Today, the OU...ting to an international effort to sequence the to...he National Science Foundation for plant genomics....tance, so improving the tomato and crop yields wil...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Saving the single cysteine: New antioxidant system found 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 9223 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 9223 2Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market Finds Frost 26 Sullivan 9221 1Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market Finds Frost 26 Sullivan 9221 2Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market Finds Frost 26 Sullivan 9221 3New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 1New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 2New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 3New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 4New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 5New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 6New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 7New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 8New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 9New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 10New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 11New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 12New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 13New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 14New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 15
...monstrated that a gel applied in the vagina provid... virus (HIV) and the herpes simplex Virus. The stu...es and Opportunistic Infections, is the first to s...in the human vagina. , The study, which was funde...tigated the efficacy of PRO 2000, a topical microb...
... causes dysentery uses a ,sword and shield, approa...blished today in Science, the team from Imperial C...hat shigella, the bacteria which causes dysentery,...nse from the immune system. , They found that shi...n system to inject proteins into human cells, (the...
...s from the United States, Sweden and Japan has dis...s sufficient to change the normal balance of cells...the risk that a cancer-causing genetic mutation wi...ople have this double protein dose as well. , In ...hers report that mice engineered to have a double ...
Other Biology News:Topical treatment shown to inhibit HIV and herpes simplex virus infection 2It's not all genetic: Common epigenetic problem doubles cancer risk in mice 2It's not all genetic: Common epigenetic problem doubles cancer risk in mice 3
DUALmembrane starter package from Dualsystems Biotech AG
Rabbit Anti-p38 alpha Polyclonal Antibody, Unconjugated from R&D Systems
Human Serum Type AB from Irvine Scientific
Anti-alpha1-Antitrypsin Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: